Drug recall · December 14, 2016
Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg recall
Why: Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg, 50 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-210-13.
- Lots / codes
Lot #: 150335, 150336, Exp. 4/2017
- Quantity
- N/A
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Nationwide
- Initiated
- November 1, 2016 · Voluntary: Firm initiated
- Classified
- December 8, 2016
- Reported
- December 14, 2016
- Ended
- February 6, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Qnasl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.